4.7 Article

GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury

Andres Hidalgo et al.

NATURE MEDICINE (2009)

Review Biotechnology & Applied Microbiology

From carbohydrate leads to glycomimetic drugs

Beat Ernst et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Review Hematology

The vessel wall and its interactions

Denisa D. Wagner et al.

BLOOD (2008)

Review Pharmacology & Pharmacy

Targeting selectins and selectin ligands in inflammation and cancer

Steven R. Barthel et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2007)

Review Medicine, Research & Experimental

Sickle cell disease: old discoveries, new concepts, and future promise

Paul S. Frenette et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Oncology

Sickle cell vaso-occlusion

EY Chiang et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2005)

Article Cardiac & Cardiovascular Systems

Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice

JD Belcher et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)

Article Cardiac & Cardiovascular Systems

Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice

DK Kaul et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)

Review Medicine, General & Internal

Sickle-cell disease

MJ Stuart et al.

LANCET (2004)

Review Biochemistry & Molecular Biology

The role of selectins in inflammation and disease

K Ley

TRENDS IN MOLECULAR MEDICINE (2003)

Article Multidisciplinary Sciences

Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm

A Turhan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Critical Care Medicine

The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy

KM Kerr et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)